EML1 anticorps (C-Term)
Aperçu rapide pour EML1 anticorps (C-Term) (ABIN632123)
Antigène
Voir toutes EML1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- EML1 antibody was raised against the C terminal of EML1
-
Purification
- Affinity purified
-
Immunogène
- EML1 antibody was raised using the C terminal of EML1 corresponding to a region with amino acids YPCSQFRAPSHIYGGHSSHVTNVDFLCEDSHLISTGGKDTSIMQWRVI
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
EML1 Blocking Peptide, (ABIN936166), is also available for use as a blocking control in assays to test for specificity of this EML1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EML1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- EML1 (Echinoderm Microtubule Associated Protein Like 1 (EML1))
-
Autre désignation
- EML1
-
Sujet
- Human echinoderm microtubule-associated protein-like is a strong candidate for the Usher syndrome type 1A gene. Usher syndromes (USHs) are a group of genetic disorders consisting of congenital deafness, retinitis pigmentosa, and vestibular dysfunction of variable onset and severity depending on the genetic type.
-
Poids moléculaire
- 92 kDa (MW of target protein)
Antigène
-